Chlorthalidone in Chronic Kidney Disease

A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 160 participants.

Also called NCT02841280

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; quadruple masking; primary purpose treatment
Phase
Phase 2
Enrolled
  • 160 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT02841280
Other papers using this trial's data
  • Chlorthalidone for Hypertension in Advanced Chronic Kidney Disease The New England journal of medicine, 2021-12-30 DOI, PubMed 34739197, PMC9119310 In the PMC Open Access subset under a licence that is not Creative Commons.

Courtesy of the U.S. National Library of Medicine.

Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
United States (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT02841280. Randomized; quadruple masking; primary purpose treatment. Start 2016-07 (actual); primary completion 2021-04 (actual). Results posted on 2022-03-31.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Chlorthalidone in Chronic Kidney Disease
Acronym
CLICK
Condition
Renal Insufficiency, Chronic
Condition
Hypertension
Intervention (Drug)
Chlorthalidone
Intervention (Drug)
Placebo
Lead sponsor
Indiana University (class: other)

Record details

Record id
cardio:ct-nct02841280
Content hash
1870715df504bbbc6be87ae76fb52151aa927ae38d4baa1b92a4f8f786df4d10